Cytek® Biosciences (CTKB) Announces $50 Million Stock Repurchase Program

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/23/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. MRNA
7. CSX
8. SPCX
9. WDC
10. QGEN

Go back to Cytek® Biosciences (CTKB) Announces $50 Million Stock Repurchase Program

Cytek Biosciences Announces $50 Million Stock Repurchase Program

June 6, 2024 8:00 AM EDT

FREMONT, Calif., June 06, 2024 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading cell analysis solutions company, today announced that its Board of Directors has approved the repurchase of up to an aggregate of $50 million of its common stock, subject to compliance with applicable law. The Companys common stock is listed on The Nasdaq Global Select Market under the symbol CTKB. The repurchase program will continue until December 31, 2024 unless extended or shortened by the Board of Directors.

Any repurchases would be made in the open... More